Back to search

Article

Genetic engineering of primary human mesenchymal stromal cells using the CRISPR/Cas9 synergistic activation mediator

2025-05-12

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Genomic editing technologies provide rich opportunities to approach inherited human diseases, but gene delivery strategies are still challenging. While engineered induced pluripotent stem cells or adeno-associated viral vectors may be associated with severe adverse effects, mesenchymal stromal cells (MSC) have abundantly been used for various cell therapeutic st...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e4e8e234-2489-5c4a-92e7-d6f58bb9e662
DOI
10.21203/rs.3.rs-6470951/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetic engineering of primary human mesenchymal stromal cells using the CRISPR/Cas9 synergistic activation mediatorDOI 10.21203/rs.3.rs-6470951/v1
Select a neighboring publication to make it the new centre.